ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION

被引:6
|
作者
Beigel, J. H. [1 ]
机构
[1] NCI, Immunoregulat Lab, Div Intramural Res, NIAID,SAIC Frederick Inc,NIH, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
CYCLOPENTANE NEURAMINIDASE INHIBITORS; IN-VIVO ACTIVITIES; A VIRUS-INFECTION; H5N1; VIRUS; PASSIVE IMMUNOTHERAPY; CELL-CULTURE; OSELTAMIVIR; EFFICACY; COMBINATION; ZANAMIVIR;
D O I
10.1358/dof.2010.035.05.1487081
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The recent pandemic of H1N1 has demonstrated the potential vulnerability of the human population to novel influenza viruses. While there is recent increased interest and effort in developing effective anti-influenza agents, few new products have entered clinical studies. This review will highlight the limited armamentarium of licensed influenza agents, and discuss novel compounds and strategies that have entered clinical studies and may therefore be imminently available to the treating clinician.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [21] Influenza A (H1N1) Virus Infection Associated with Hemiplegia
    Li, Xiaoqing
    INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (11) : 1338 - 1339
  • [22] Influenza A (H1N1) Virus Infection Associated with Hemiplegia
    Xiaoqing Li
    The Indian Journal of Pediatrics, 2010, 77 : 1338 - 1339
  • [23] Influenza A/H1N1 (2009) infection in pregnancy-an Asian perspective
    Lim, M. L.
    Chong, C. Y.
    Tee, W. S. N.
    Lim, W. Y.
    Chee, J. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (05) : 551 - 556
  • [24] Transmission of Novel Influenza A(H1N1) in Households with Post-Exposure Antiviral Prophylaxis
    van Boven, Michiel
    Donker, Tjibbe
    van der Lubben, Mariken
    van Gageldonk-Lafeber, Rianne B.
    Beest, Dennis E. Te
    Koopmans, Marion
    Meijer, Adam
    Timen, Aura
    Swaan, Corien
    Dalhuijsen, Anton
    Hahne, Susan
    van den Hoek, Anneke
    Teunis, Peter
    van der Sande, Marianne A. B.
    Wallinga, Jacco
    PLOS ONE, 2010, 5 (07):
  • [25] Myocardial dysfunction during H1N1 influenza infection
    Fagnoul, David
    Pasquier, Pierre
    Bodson, Laurent
    Ortiz, Julian Arias
    Vincent, Jean-Louis
    De Backer, Daniel
    JOURNAL OF CRITICAL CARE, 2013, 28 (04) : 321 - 327
  • [26] Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus
    Rungrotmongkol, Thanyada
    Intharathep, Pathumwadee
    Malaisree, Maturos
    Nunthaboot, Nadtanet
    Kaiyawet, Nopphorn
    Sompornpisut, Pornthep
    Payungporn, Sanchai
    Poovorawan, Yong
    Hannongbua, Supot
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (03) : 390 - 394
  • [27] Influenza, including the novel H1N1, in organ transplant patients
    Ison, Michael G.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (04) : 365 - 373
  • [28] Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults
    Önder Ergönül
    Servet Alan
    Öznur Ak
    Fatman Sargın
    Arzu Kantürk
    Alper Gündüz
    Derya Engin
    Oral Öncül
    Ilker Inanc Balkan
    Bahadir Ceylan
    Nur Benzonana
    Saadet Yazıcı
    Funda Şimşek
    Nuray Uzun
    Asuman İnan
    Eren Gulhan
    Meral Ciblak
    Kenan Midilli
    Mustafa Ozyurt
    Selim Badur
    Serap Gencer
    Ozcan Nazlıcan
    Serdar Özer
    Nail Özgüneş
    Taner Yıldırmak
    Turan Aslan
    Pasa Göktaş
    Nese Saltoğlu
    Muzaffer Fincancı
    Ali Ihsan Dokucu
    Haluk Eraksoy
    BMC Infectious Diseases, 14
  • [29] Clinical Predictors of Novel Influenza A (H1N1) Infection in Korea
    Kim, Choon Ok
    Nam, Chung Mo
    Lee, Duk-Chul
    Han, Sang Hoon
    Lee, Ji Won
    YONSEI MEDICAL JOURNAL, 2010, 51 (06) : 895 - 900
  • [30] Stroke as a Complication of H1N1 Influenza Infection: A Case Study
    Krummel-McCracken, Kirsten
    CRITICAL CARE NURSE, 2011, 31 (04) : E1 - E8